Navigation Links
Medifast, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Thursday, July 30, 2009
Date:7/23/2009

OWINGS MILLS, Md., July 23 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) announced today that it will release second quarter fiscal year 2009 financial results for the period ended June 30, 2009 on Thursday, July 30, 2009 prior to the opening of the market. The Company will hold a conference call and web cast to discuss the results on Thursday, July 30, 2009 at 11:00 a.m. ET.

Interested parties can access the call by dialing (877) 407-0782 or (201) 689-8567, or can listen via a live Internet web cast, which can be found at www.choosemedifast.com in the section marked "Investor Relations." A replay of the call is available via web cast at www.choosemedifast.com until October 30, 2009 or by playback at (877) 660-6853 or (201) 612-7415 through August 8, 2009. Please use account #286 and conference #328083 for the replay.

About Medifast, Inc.

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by 15,000 physicians and used by over one million customers. It is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) national network of physicians, 3) medically supervised Medifast Weight Control Centers, and 4) the Take Shape For Life direct-selling division, a network of health coaches. Medifast was founded in 1980 and is
'/>"/>

SOURCE Medifast, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Medifast, Inc. Announces Support for Microsoft HealthVault
2. Medifast, Inc. Receives Approval to Sell Medifast Weight Control Centers Franchises in Seven Additional States
3. Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008
4. Medifast, Inc. Director of Research & Development Co-Authors Health Book
5. Medifast, Inc. to Announce Fourth Quarter and Fiscal Year-End Results on Wednesday, March 12, 2008
6. Medifast, Inc. Names Barry B. Bondroff, CPA to Board of Directors
7. Medifast, Inc. to Present at the Canaccord Adams Diabetes & Obesity Conference
8. Medifast, Inc. to Announce Third Quarter of Fiscal Year 2008 Financial Results on Thursday, November 6, 2008
9. Medifast, Inc. Responds to False Claims
10. Medifast, Inc. Announces Appointment of Two Additional Independent Board Members
11. Medifast, Inc. to Announce Fourth Quarter and Fiscal Year 2008 Financial Results on Thursday, March 12, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... June 29, 2015 , ... Scientists ... approach to build nearly complete genomes by combining high-throughput DNA sequencing with genome ... important for their association with human disease, but previously difficult to detect. The ...
(Date:6/29/2015)... ... ... USA Today reported on June 18th the overdose death rate has ... rest of the nation’s growing overdose death rates in 26 other states the U.S. ... stop the increasing overdose trend from continuing: , , Encourage and ...
(Date:6/29/2015)... ... June 29, 2015 , ... New research released ... than 10 percent of U.S. state and local governments have implemented Next Generation ... deadline for NG9-1-1. , “Mobile phones have surpassed land lines as the ...
(Date:6/29/2015)... Detroit, MI (PRWEB) , ... June 29, 2015 , ... ... offer Kybella™ injection to clients for the reduction of the double chin and redefining ... can cause a person to look much older and heavier causing the person distress ...
(Date:6/29/2015)... New York, NY (PRWEB) , ... June 29, 2015 , ... ... of Radiation Oncology, Care to Care. , Dr. Faber will lead the Radiation Oncology ... complexities of treatment through the use of Care to Care’s proprietary evidence based criteria. ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Overdose Death Rates Decreased in Florida as of 2015 2Health News:Overdose Death Rates Decreased in Florida as of 2015 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4Health News:FACE Detroit Skin and Wellness Clinic Introduces Newly FDA Approved Kybella for the elimination of the Double Chin. 2Health News:Care to Care, LLC Appoints a New Section Chief of Radiation Oncology 2Health News:Care to Care, LLC Appoints a New Section Chief of Radiation Oncology 3
... a,non-profit organization focused on prevention and recovery from Autism,ADHD ... organization,through three major steps:, 1. Jenny McCarthy, Deirdre ... Ms. McCarthy is a best-selling author, actress, activist, ... latest book, Louder than Words,profiled her own son,s journey ...
... Product That Gives Consumers an All-Natural Cottage Cheese Containing ... ... Beginning in early June, a new,cottage cheese with more healthy ... with Pro-Active,Nutrients. The first to offer this nutrition and health ...
... Management Society of America to Sponsor MEP Workshop at Annual ... ... May 22 The Population Health Impact,Institute (PHII), a non-profit 501(c)(3) ... draft Methods Evaluation,Process(TM) (MEP(TM)) Accreditation Standards. The comment period ends on,July ...
... An experimental drug has blocked the progression of ... form of the disease, new research shows. , The ... called histone deacetylase (HDAC) inhibitors, compounds designed to reactivate ... off by the cancer process. , The study, conducted ...
... that in the dog-eat-dog, look-out-for-No. 1, highly competitive business ... to succeed as an entrepreneur. That statement may sound ... A team led by a University of Missouri researcher ... and women decide to pursue entrepreneurship as a viable ...
... 22 Parks Associates and CEA(R) today,announced ... free pre-show session,at CONNECTIONS(TM) on June 24. ... coalition of the finest healthcare and technology,companies ... quality of,personal healthcare by establishing a system ...
Cached Medicine News:Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 3Health News:New Friendship Cottage Cheese Boosts Digestive & Bone Health 2Health News:New Friendship Cottage Cheese Boosts Digestive & Bone Health 3Health News:Population Health Impact Institute Releases Methods Evaluation Process(TM) (MEP(TM)) Accreditation Standards for Public Comment Period 2Health News:Experimental agent blocks prostate cancer in animal study 2Health News:Taking care of business shouldn't be just for men 2Health News:Continua Health Alliance Provides Insight Into Next Generation of Digital Health at CONNECTIONS(TM) 2
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: